US2023357863A1PendingUtilityA1
Synthetic nucleic acid control molecules
Est. expiryDec 19, 2033(~7.4 yrs left)· nominal 20-yr term from priority
C12Q 1/6886C12N 15/11C12Q 1/6876C12Q 2600/154C12Q 2600/156C12Q 2600/166
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides synthetic DNA strands that find use as controls or in nucleic acid testing methods. In particular, provided herein are synthetic DNA strands of known composition for use as control molecules in stool DNA testing, e.g., of mutations and/or methylation of DNA isolated from stool samples.
Claims
exact text as granted — not AI-modified1 .- 78 . (canceled)
79 . A method of characterizing a methylation assay, comprising:
i) providing a run control composition that comprises:
a) a number of copies of a first synthetic DNA fragment comprising a sequence of a portion of a human biomarker DNA, wherein the sequence is synthesized to comprise a sequence region containing a number and pattern of cytosines and cytosine-phosphate-guanosine (CpG) dinucleotides in which each of the cytosines in the CpG dinucleotides in the pattern comprises a 5-methyl;
b) a number of copies of a second synthetic DNA fragment comprising the same sequence of the same portion of the human biomarker DNA as the first synthetic DNA, and comprising a sequence region comprising the same number and pattern of cytosines and CpG dinucleotides as the sequence region in the first synthetic DNA fragment, wherein none of the cytosines in the pattern comprises a 5-methyl; and
c) fish DNA; and
ii) applying the methylation assay to the run control composition, wherein cytosines in the CpG dinucleotides in the pattern are detected.
80 . The method of claim 79 , wherein cytosines in the CpG dinucleotides in the pattern that do not comprise a 5-methyl are detected.
81 . The method of claim 79 , wherein cytosines in the CpG dinucleotides in the pattern that comprise a 5-methyl are detected.
82 . The method of claim 79 , wherein the methylation assay comprises treating the run control composition with a reagent that converts unmethylated cytosine bases to uracil bases.
83 . The method of method of claim 82 , wherein the reagent comprises bisulfite.
84 . The method of claim 82 , wherein the methylation assay comprises assaying treated run control DNA to detect a number of copies of treated first synthetic DNA fragment and a number of copies of treated second synthetic DNA fragment.
85 . The method of claim 84 , wherein the number of copies of treated first synthetic DNA fragment and the number of copies of treated second synthetic DNA fragment are detected in separate reaction mixtures.
86 . The method of claim 85 , wherein the reaction mixtures comprise one or more of DNA polymerase, deoxynucleoside triphosphates, amplification buffer, primer oligonucleotides, probe oligonucleotide, and magnesium salt.
87 . The method of claim 79 , wherein the methylation assay comprises an invasive cleavage assay.
88 . The method of claim 87 , wherein the invasive cleavage assay is a flap assay.
89 . The method of claim 88 , wherein the flap assay comprises using one or more reagents selected from the group consisting of an invasive oligonucleotide, a flap oligonucleotide, a flap endonuclease, and a FRET cassette.
90 . The method of claim 79 , wherein the first synthetic DNA fragment and the second synthetic DNA fragment are double-stranded.
91 . The method of claim 79 , wherein the first synthetic DNA fragment and the second synthetic DNA fragment each further comprise a second sequence region containing a CpG dinucleotide in which the cytosine does not comprise a 5-methyl.
92 . The method of claim 79 , wherein the run control composition comprises at least 50 μg/mL fish DNA.
93 . The method of claim 79 , wherein the run control composition further comprises a DNA stabilization buffer comprising Tris-HCl, EDTA, and NaCl.
94 . The method of claim 93 , wherein the run control composition has a volume and wherein the DNA stabilization buffer is 80% of the volume of the run control composition, and wherein the DNA stabilization buffer comprises 500 mM Tris-HCl, 150 mM EDTA, and 10 mM NaCl, pH 9.
95 . The method of claim 79 , wherein the run control composition further comprises a synthetic DNA fragment comprising a sequence from a human reference gene.Join the waitlist — get patent alerts
Track US2023357863A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.